Ann Mullally

7.6k total citations
81 papers, 3.9k citations indexed

About

Ann Mullally is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Ann Mullally has authored 81 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Genetics, 54 papers in Hematology and 37 papers in Molecular Biology. Recurrent topics in Ann Mullally's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (57 papers), Acute Myeloid Leukemia Research (28 papers) and Chronic Myeloid Leukemia Treatments (24 papers). Ann Mullally is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (57 papers), Acute Myeloid Leukemia Research (28 papers) and Chronic Myeloid Leukemia Treatments (24 papers). Ann Mullally collaborates with scholars based in United States, United Kingdom and Germany. Ann Mullally's co-authors include Benjamin L. Ebert, Rebekka K. Schneider, Ross L. Levine, Nancy Berliner, Adam J. Mead, Alison M. Schram, D. Gary Gilliland, Edwin Chen, Steven Lane and Fátima Al‐Shahrour and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Genetics.

In The Last Decade

Ann Mullally

77 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Mullally United States 30 2.3k 2.1k 2.1k 739 605 81 3.9k
Valeria Visconte United States 29 1.8k 0.8× 860 0.4× 1.4k 0.7× 240 0.3× 756 1.2× 181 3.2k
Enrico Gottardi Italy 24 2.9k 1.3× 1.3k 0.6× 1.4k 0.7× 469 0.6× 224 0.4× 79 3.7k
Eibhlin Conneally Ireland 26 1.6k 0.7× 1.2k 0.6× 877 0.4× 366 0.5× 500 0.8× 82 2.7k
E Bruno United States 33 1.7k 0.7× 858 0.4× 991 0.5× 300 0.4× 556 0.9× 61 2.9k
Jean‐Michel Cayuela France 33 2.1k 0.9× 837 0.4× 1.0k 0.5× 380 0.5× 552 0.9× 101 3.8k
Koiti Inokuchi Japan 28 1.2k 0.5× 687 0.3× 740 0.4× 275 0.4× 394 0.7× 145 2.2k
J. Thiele Germany 27 1.2k 0.5× 1.4k 0.6× 917 0.4× 496 0.7× 269 0.4× 101 2.5k
Christoph Walz Germany 25 792 0.3× 679 0.3× 650 0.3× 694 0.9× 466 0.8× 70 2.1k
AC Eaves Canada 39 4.2k 1.8× 2.1k 1.0× 1.6k 0.8× 435 0.6× 1.3k 2.2× 83 6.0k
Katharina S. Götze Germany 29 2.7k 1.2× 1.3k 0.6× 1.7k 0.8× 75 0.1× 380 0.6× 130 3.9k

Countries citing papers authored by Ann Mullally

Since Specialization
Citations

This map shows the geographic impact of Ann Mullally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Mullally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Mullally more than expected).

Fields of papers citing papers by Ann Mullally

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Mullally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Mullally. The network helps show where Ann Mullally may publish in the future.

Co-authorship network of co-authors of Ann Mullally

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Mullally. A scholar is included among the top collaborators of Ann Mullally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Mullally. Ann Mullally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hormoz, Sahand, Vijay G. Sankaran, & Ann Mullally. (2024). Evolution of myeloproliferative neoplasms from normal blood stem cells. Haematologica. 110(4). 840–849.
2.
Mullally, Ann, et al.. (2023). Antibody targeting of mutant calreticulin in myeloproliferative neoplasms. Journal of Cellular and Molecular Medicine. 28(5). e17896–e17896. 4 indexed citations
3.
Jutzi, Jonas S., Anna E. Marneth, Ángel Guerra-Moreno, et al.. (2022). CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response. Leukemia. 37(2). 359–369. 13 indexed citations
4.
Jutzi, Jonas S., Anna E. Marneth, Ángel Guerra-Moreno, et al.. (2022). Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood. 140(11). 1291–1304. 11 indexed citations
5.
Vining, Kyle H., Anna E. Marneth, Kwasi Adu‐Berchie, et al.. (2022). Mechanical checkpoint regulates monocyte differentiation in fibrotic niches. Nature Materials. 21(8). 939–950. 55 indexed citations
6.
Rocha, Azucena, Ferdinand von Meyenn, Donal P. McLornan, et al.. (2021). Hydroxycarbamide effects on DNA methylation and gene expression in myeloproliferative neoplasms. Genome Research. 31(8). 1381–1394. 4 indexed citations
7.
Egeren, Debra Van, Shichen Liu, Maximilian Nguyen, et al.. (2021). Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms. Experimental Hematology. 107. 14–19. 8 indexed citations
8.
Mullally, Ann, John Hood, Claire Harrison, & Ruben A. Mesa. (2020). Fedratinib in myelofibrosis. Blood Advances. 4(8). 1792–1800. 60 indexed citations
9.
Ng, Julie, Fei Guo, Anna E. Marneth, et al.. (2020). Augmenting emergency granulopoiesis with CpG conditioned mesenchymal stromal cells in murine neutropenic sepsis. Blood Advances. 4(19). 4965–4979. 10 indexed citations
10.
How, Joan, Orly Leiva, Thomas Bogue, et al.. (2020). Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia. Leukemia Research. 98. 106459–106459. 22 indexed citations
11.
Jutzi, Jonas S. & Ann Mullally. (2020). Remodeling the Bone Marrow Microenvironment – A Proposal for Targeting Pro-inflammatory Contributors in MPN. Frontiers in Immunology. 11. 2093–2093. 17 indexed citations
12.
Elf, Shannon, et al.. (2017). Functional and Molecular Basis of Thrombopoietin Receptor Activation By Mutant Calreticulin. Blood. 130. 382. 1 indexed citations
13.
Hobbs, Gabriela, et al.. (2017). The Development and Use of Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms. Hematology/Oncology Clinics of North America. 31(4). 613–626. 21 indexed citations
14.
Elf, Shannon, Nouran S. Abdelfattah, Edwin Chen, et al.. (2016). Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation. Cancer Discovery. 6(4). 368–381. 189 indexed citations
15.
Obeng, Esther A., Michael Seiler, Michelle C. Chen, et al.. (2016). Physiologic Expression of Sf3b1 K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation. Cancer Cell. 30(3). 404–417. 263 indexed citations
16.
Chen, Edwin, Jong Sook Ahn, Lawrence J. Breyfogle, et al.. (2015). RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability. Cell Reports. 13(11). 2345–2352. 24 indexed citations
17.
Mullally, Ann, Claudia Bruedigam, Luke Poveromo, et al.. (2013). Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera. Blood. 121(18). 3692–3702. 126 indexed citations
18.
Lin, Xiaoqing, Kim L. Rice, Monica Buzzai, et al.. (2012). miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation. Leukemia. 27(2). 344–352. 49 indexed citations
19.
Mullally, Ann & Benjamin L. Ebert. (2010). NF1 Inactivation Revs Up Ras in Adult Acute Myelogenous Leukemia. Clinical Cancer Research. 16(16). 4074–4076. 9 indexed citations
20.
Mullally, Ann, Steven Lane, Brian Ball, et al.. (2010). Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells. Cancer Cell. 17(6). 584–596. 285 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeria Visconte Breakdown of academic impact, for papers by Enrico Gottardi Breakdown of academic impact, for papers by Eibhlin Conneally Breakdown of academic impact, for papers by E Bruno Breakdown of academic impact, for papers by Jean‐Michel Cayuela Breakdown of academic impact, for papers by Koiti Inokuchi Breakdown of academic impact, for papers by J. Thiele Breakdown of academic impact, for papers by Christoph Walz Breakdown of academic impact, for papers by AC Eaves Breakdown of academic impact, for papers by Katharina S. Götze
Rankless by CCL
2026